IMAC Holdings Inc (OQ:BACK)
Business Focus: Hospitals, Clinics & Primary Care Services
May 07, 2024 08:30 am ET
IMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business
On May 1, 2024, as previously announced, pursuant to that certain Settlement and Release Agreement, by and between IMAC Holdings, Inc. (NASDAQ: BACK) (“BACK”) and Theralink Technologies, Inc. (“Theralink”), BACK acquired the assets of Theralink,...
Feb 13, 2024 06:45 am ET
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, announced today that...
Dec 26, 2023 08:31 am ET
Thinking about buying stock in Safety Shot, Xpeng Inc, Archer Aviation, IMAC Holdings, or Alarum Technologies?
NEW YORK, Dec. 26, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SHOT, XPEV, ACHR, BACK, and ALAR.
Nov 13, 2023 02:15 pm ET
Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4
Theralink Technologies, Inc. (OTC: THER) (“Theralink”), a precision oncology company with its exclusive commercial RPPA (reverse phase protein array) technology that can help predict which FDA-approved drug is effective in each cancer, today with...
Nov 03, 2023 09:15 am ET
Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board
Theralink Technologies, Inc. (OTC: THER) (“Theralink”), a precision oncology company with its exclusive commercial RPPA (reverse phase protein array) technology that can help predict which FDA-approved drug is effective in each cancer, today...
Oct 04, 2023 09:15 am ET
Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023
Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein and protein assay for breast cancer, today announces the filing of a Form S-4 with the Securities and Exchange...
Sep 27, 2023 04:30 pm ET
IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”) today announced that it has received notice from The Nasdaq Stock Market LLC informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq...
Sep 07, 2023 12:45 pm ET
IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”) today announced a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-30 (the “Reverse Split”) and that it had filed a Certificate of Amendment to the...
Jul 26, 2023 09:25 am ET
IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments, announced today that it entered into a definitive securities...
Jun 28, 2023 04:30 pm ET
IMAC Holdings Annual Meeting of Shareholders Reminder
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, reminds its shareholders that its Annual...
Jun 27, 2023 09:20 am ET
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer
Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein and protein assay for breast cancer in the process of merging with IMAC Holdings, Inc. (NASDAQ: BACK), today announces...
Jun 04, 2023 08:10 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BACK, GNL, RTL
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: IMAC Holdings, Inc. (NASDAQ: BACK)’s...
Jun 03, 2023 08:17 pm ET
Lifshitz Law PLLC Announces Investigations of APGN, GNL, RTL, and BACK
Apexigen, Inc. (NASDAQ: APGN) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of APGN and Pyxis Oncology, Inc. Under the terms of the proposed merger, APGN shareholders will...
May 31, 2023 01:00 pm ET
Moore Kuehn Encourages VECT, EMBK, BACK, and RADI Investors to Contact Law Firm
NEW YORK, May 31, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.
May 28, 2023 09:58 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GHL, DM, BACK
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Greenhill & Co., Inc. (NYSE: GHL)’s...
May 23, 2023 09:44 am ET
BACK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of IMAC Holdings, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of IMAC Holdings, Inc. (NASDAQ: BACK) and Theralink Technologies, Inc. is fair to IMAC shareholders.
May 23, 2023 09:43 am ET
Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company
Theralink Technologies, Inc. (OTC: THER) (“Theralink”) and IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”), today announced that they have entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) under which Theralink will merge...
May 23, 2023 08:30 am ET
Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company
Theralink's patented technology is helping to solve a significant problem in cancer treatment by providing game changing technology that can predict which FDA-approved drugs may be effective in each solid tumor cancer
Mar 31, 2023 08:00 pm ET
IMAC Holdings Reports Year End 2022 Financial Results and Corporate Update
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today reported its...
Mar 20, 2023 07:30 am ET
IMAC Holdings and Brain Scientific Announce a Strategic Merger to Create Synergistic End-To-End Neurological Solution
IMAC Holdings, Inc. (“IMAC”)(Nasdaq: BACK), a regenerative rehabilitation company focused on treating musculoskeletal and neurodegenerative disease, and Brain Scientific, Inc. (“Brain Scientific”)(OTCQB:BRSFD), a Florida-based applied science...
Mar 01, 2023 09:30 am ET
IMAC Holdings, Inc announces the sale of The BackSpace
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), announces today it has completed the sale of The BackSpace for an undisclosed price to Curis Functional Health. The BackSpace offers convenient and affordable spinal health and wellness...
Nov 15, 2022 06:00 am ET
IMAC Holdings Announces Third Quarter Results
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” “BACK” or the “Company”), today reported its preliminary financial results for the third quarter ended September 30, 2022. Financial and Corporate Highlights from Q3 2022: Total Revenue increased 9% to...
Nov 03, 2022 08:30 am ET
IMAC Holdings, Inc. Launches E-Commerce Website for Vitamin and Supplement Line
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), announces today it has launched an e-commerce platform to retail its vitamin and supplement products to consumers nationwide. IMAC recently launched Vita Eternum, an organic, whole-food...
Oct 21, 2022 10:30 am ET
IMAC Holdings, Inc. Hosts Hall of Fame Athlete Panel at the Evoke Conference to Launch Whole Food Supplement Partnership
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), announces today it is partnering with Evoke Chiropractic Coaching to educate and offer its new organic, whole food supplements to its network of physician offices. The partnership begins...
Sep 09, 2022 09:22 am ET
IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or “the Company”), today announces it has completed the third cohort of its Phase 1 clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the...
Sep 07, 2022 08:30 am ET
Biote Announces Strategic Partnership with IMAC Holdings, Inc.
biote Corp. (Nasdaq: BTMD)(“Biote” or the “Company”), a high growth, differentiated medical practice-building business within the hormone optimization space, today announced that it has entered into a partnership with IMAC Holdings, Inc. (Nasdaq:...
Sep 01, 2022 09:44 am ET
IMAC Holdings, Inc. Announces Addition of Medical Weight Loss Services to IMAC Regeneration Centers
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), announces today it is accepting patients for medical weight loss services at IMAC Regeneration Centers. The medical weight loss service will launch in three facilities this month. “We...
Aug 16, 2022 04:00 pm ET
IMAC Holdings, Inc. Announces Closing of $3.9 Million Registered Direct and Private Placement Offerings
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments, today announced the closing of its previously announced...
Aug 15, 2022 11:30 am ET
IMAC Holdings Reports Record Revenue of $5M in Second Quarter
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” “BACK” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic and neurological treatments, today reported its preliminary financial...
Aug 12, 2022 09:16 am ET
IMAC Holdings, Inc. Announces $3.9 Million Registered Direct and Private Placement
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments, today announced that it has entered into a securities purchase...
Aug 10, 2022 08:30 am ET
IMAC Holdings, Inc. Adds Stretch Services at The BackSpace
IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), announces today the addition of stretching services at The BackSpace. The BackSpace locations now offer chiropractic care, percussion therapy, and stretching services to consumers on...
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.